{"id":"https://openalex.org/W73090406","doi":null,"title":"Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits.","display_name":"Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits.","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W73090406","mag":"73090406","pmid":"https://pubmed.ncbi.nlm.nih.gov/22186318"},"language":"en","primary_location":{"id":"pmid:22186318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22186318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pakistan journal of pharmaceutical sciences","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W73090406"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010610232","display_name":"M. Naveed Yasin","orcid":"https://orcid.org/0000-0001-7896-2937","observed_orcids":["https://orcid.org/0000-0001-7896-2937"]},"institutions":[{"id":"https://openalex.org/I160968435","display_name":"University of Sargodha","ror":"https://ror.org/0086rpr26","country_code":"PK","type":"education","lineage":["https://openalex.org/I160968435"]}],"countries":["PK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Muhammad Naveed Yasin","raw_affiliation_strings":["Faculty of Pharmacy, University of Sargodha, Sargodha, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, University of Sargodha, Sargodha, Pakistan","institution_ids":["https://openalex.org/I160968435"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101982079","display_name":"Shahzad Hussain","orcid":"https://orcid.org/0000-0002-8849-6455","observed_orcids":["https://orcid.org/0000-0002-8849-6455"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shahzad Hussain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103589762","display_name":"Farnaz Malik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Farnaz Malik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Abdul Hameed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Abdul Hameed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101616800","display_name":"Tipu Sultan","orcid":"https://orcid.org/0000-0003-1957-1391","observed_orcids":["https://orcid.org/0000-0003-1957-1391"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tipu Sultan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Fahim Qureshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fahim Qureshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108719631","display_name":"Humayun Riaz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Humayun Riaz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ghazala Perveen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ghazala Perveen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084094863","display_name":"Amina Wajid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amina Wajid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7977,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.64495425,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"25","issue":"1","first_page":"117","last_page":"121"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chloramphenicol","display_name":"chloramphenicol","score":0.9399999976158142},{"id":"https://openalex.org/keywords/niosomes","display_name":"niosomes","score":1.0},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.9409999847412109},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8970000147819519},{"id":"https://openalex.org/keywords/encapsulation-efficiency","display_name":"encapsulation efficiency","score":0.9850000143051147},{"id":"https://openalex.org/keywords/zeta-potential","display_name":"zeta potential","score":0.8519999980926514},{"id":"https://openalex.org/keywords/viscosity","display_name":"viscosity","score":0.5419999957084656},{"id":"https://openalex.org/keywords/niosome-stability","display_name":"niosome stability","score":0.628000020980835},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.847000002861023},{"id":"https://openalex.org/keywords/albino-rabbits","display_name":"albino rabbits","score":0.7929999828338623}],"concepts":[{"id":"https://openalex.org/C72918618","wikidata":"https://www.wikidata.org/wiki/Q1993211","display_name":"Niosome","level":4,"score":0.9561635255813599},{"id":"https://openalex.org/C2778473333","wikidata":"https://www.wikidata.org/wiki/Q274515","display_name":"Chloramphenicol","level":3,"score":0.6458304524421692},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5851101875305176},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5575684309005737},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.53748619556427},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5076631307601929},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.469525009393692},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.45765814185142517},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39302051067352295},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3152456283569336},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.20618122816085815},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1851368546485901},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14777147769927979},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.12964484095573425},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11594220995903015},{"id":"https://openalex.org/C130316041","wikidata":"https://www.wikidata.org/wiki/Q189206","display_name":"Vesicle","level":3,"score":0.08824777603149414},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08687308430671692},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.06337288022041321},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002701","descriptor_name":"Chloramphenicol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002701","descriptor_name":"Chloramphenicol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002701","descriptor_name":"Chloramphenicol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003234","descriptor_name":"Conjunctivitis, Bacterial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005123","descriptor_name":"Eye","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013203","descriptor_name":"Staphylococcal Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22186318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22186318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pakistan journal of pharmaceutical sciences","raw_type":"Comparative Study"},{"id":"mag:73090406","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22186318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W38327774","https://openalex.org/W187793109","https://openalex.org/W1592834760","https://openalex.org/W1597778670","https://openalex.org/W1969453607","https://openalex.org/W2014325374","https://openalex.org/W2027658624","https://openalex.org/W2028205103","https://openalex.org/W2033632772","https://openalex.org/W2034667781","https://openalex.org/W2058285094","https://openalex.org/W2062144863","https://openalex.org/W2072752370","https://openalex.org/W2093692232","https://openalex.org/W2119364806","https://openalex.org/W2124838852","https://openalex.org/W2127570357","https://openalex.org/W2316910119","https://openalex.org/W3203782524"],"related_works":["https://openalex.org/W7131863208","https://openalex.org/W2465710044","https://openalex.org/W2951274408","https://openalex.org/W2142012358","https://openalex.org/W2671646452","https://openalex.org/W2402852268","https://openalex.org/W2052129346","https://openalex.org/W2014325374","https://openalex.org/W2460171246","https://openalex.org/W2182382271"],"abstract_inverted_index":{"Niosomes":[0,192],"has":[1],"gained":[2],"tremendous":[3],"popularity":[4],"as":[5,49,148],"ultimate":[6,195],"drug":[7,45,65,83,156,164,176,197,202],"carrier.":[8],"Lot":[9],"of":[10,19,43,81,106,119,122,153,161],"research":[11],"work":[12],"is":[13],"being":[14],"carried":[15],"out":[16],"on":[17,28],"preparation":[18],"niosomes":[20,36,149,173],"for":[21,70],"ophthalmic":[22,196],"use":[23],"having":[24],"no":[25],"significant":[26],"effect":[27],"vision":[29],"and":[30,46,56,78,93,159,182,205],"its":[31],"sustained":[32,185,204],"release":[33,66,186,201],"pattern.":[34,207],"Chloramphenicol":[35,99,135],"were":[37,91,112,193],"prepared":[38],"using":[39],"two":[40],"different":[41],"ratios":[42],"cholesterol,":[44],"surfactant,":[47],"termed":[48],"EIN-1,":[50],"EIN-2":[51,74],"by":[52,157,165],"ether":[53],"injection":[54],"method":[55],"their":[57],"entrapment":[58,77],"efficiency,":[59],"particle":[60],"size.":[61],"The":[62,73],"in":[63,138,141,177,179,203],"vitro":[64],"pattern":[67,187],"was":[68,96,125,132],"observed":[69],"ten":[71],"hours.":[72,86],"showed":[75,183],"90%":[76],"released":[79,150,174],"81%":[80,160],"entrapped":[82,155,163],"after":[84],"10":[85],"Zeta":[87],"potential":[88],"&":[89],"viscosity":[90],"determined":[92,206],"in-vivo":[94],"comparison":[95],"made":[97],"with":[98,134],"eye":[100,136,178],"drops":[101,137],"where":[102],"it":[103],"exhibited":[104],"Cmax":[105],"15":[107],"\u03bc":[108],"g/ml.":[109],"Stability":[110],"studies":[111,145],"done":[113],"to":[114,200],"determine":[115],"shelf":[116],"life.":[117],"MIC":[118],"selected":[120],"strain":[121],"S.":[123],"aureus":[124],"also":[126],"determined.":[127],"EIN":[128,166],"2":[129],"niosomal":[130],"suspension":[131],"compared":[133],"experimental":[139],"conjunctivitis":[140],"albino":[142],"rabbits.":[143],"In-vitro":[144],"are":[146],"encouraging":[147],"about":[151],"75%":[152],"total":[154,162],"EIN-1":[158],"2.":[167],"In":[168],"vivo":[169],"study":[170],"shows":[171],"that":[172],"the":[175,190],"acceptable":[180],"range":[181],"a":[184],"without":[188],"affecting":[189],"vision.":[191],"found":[194],"carriers":[198],"capable":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W73090406","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
